Cardiology Today


The following articles appeared in the print edition of CARDIOLOGY TODAY.

Table of Contents
Cover Story

Hospital readmissions present a complex, costly issue for US cardiologists


How cardiologists are paid

L. Samuel Wann, MD, MACC, FESC

FDA approvals

Sapien XT FDA approved for high-risk, inoperable patients

FDA News

FDA: No clear link between olmesartan, CV risk among patients with diabetes

In the Journals

Antidepressant use during pregnancy not linked to risk for infant cardiac defects

Gender-specific research, strategies may improve accuracy of ischemic heart disease diagnosis in women

Regular use of some NSAIDs moderately increased CV risk in postmenopausal women

Prophylactic ICDs improved survival in patients with less severe HF

HPS2-THRIVE published: Niacin did not benefit patients with vascular disease

Evidence suggests causal link between vitamin D deficiency, hypertension

Diabetes, vascular disease connection differs by phenotype

Meet the Board

Franz H. Messerli, MD: A leading authority on hypertension management

Meeting News Coverage

Orbital atherectomy improved long-term outcomes in high-risk patients

3-D quantitative coronary angiography reliably identifies occult severe lesions

RadiCure: Device reduced radiation exposure during cardiac catheterization

Smart technology use common, beneficial in congenital cath lab

DAPT duration after endovascular intervention did not affect major adverse events

Low operator PCI volume linked to worse outcomes, higher cost

Smokers more vulnerable to arterial plaque ruptures

Trial Scorecards

Trial Scorecard: TESLA

Trial Scorecard: VIRGO

Trial Scorecard: SLIMM-T2D

Trial Scorecard: GARY

Trial Scorecard: BtB

Trial Scorecard: IQ-CATEGORIZE

Trial Scorecard: OACIS

Trial Scorecard: MrOS